Evidence map›Paper›PMID 14671131›Full record

ArticleJournal of virology2004

An aromatic side chain is required at residue 8 of SU for fusion of ecotropic murine leukemia virus.

Zhaohui Qian, Lorraine M Albritton

Open access · greenAbstract read
In one paragraph

Article in Journal of virology, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 55% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 7 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Zhaohui QianDepartment of Molecular Sciences, University of Tennessee Health Science Center, Memphis, Tennessee 38163, USA.
Lorraine M Albritton
University of Tennessee Health Science Center · US

Funding

MUTATIONAL AND PHYSICAL ANALYSIS OF THE MULV-E RECEPTORR01AI033410 · NIAID · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI ALBRITTON, LORRAINE M. · 1993 to 2007
$1.5M
NIAID NIH HHS AI33410NIAID NIH HHS R01 AI033410
6 · The paper itself

Abstract

The surface glycoprotein (SU) of most gammaretroviruses contains a conserved histidine at its amino terminus. In ecotropic murine leukemia virus SU, replacement of histidine 8 with arginine (H8R) or deletion of H8 (H8del) abolishes infection and cell-cell fusion but has no effect on binding to the cellular receptor. We report here that an aromatic ring side chain is essential to the function of residue 8. The size of the aromatic ring appears to be important, as does its ability to form a hydrogen bond. In addition, infection by all of the nonaromatic amino acid substitutions could be partially rescued by the addition of two suppressor mutations (glutamine 227 to arginine [Q227R] and aspartate 243 to tyrosine [D243Y]) or by exposure to chlorpromazine, an agent that induces fusion pores in hemifusion intermediates to complete fusion, suggesting that, like the previously described H8R mutant, the mutants reported here also arrest membrane fusion at the hemifusion state. We propose that H8 is a key switch-point residue in the conformation changes that lead to membrane fusion and present a possible mechanism for how its substitution arrests fusion at the hemifusion state.

Indexed as

Membrane FusionAnimalsChlorpromazineLeukemia Virus, MurineMiceMutationNIH 3T3 CellsProtein ConformationReceptors, VirusStructure-Activity RelationshipViral Envelope ProteinsChlorpromazineReceptors, VirusViral Envelope Proteins

Identifiers

PMID14671131
PMCPMC303429
OpenAlexW2165384050

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.